Trial Fails For Columbia Laboratories
Columbia Laboratories Inc.'s (CBRX) late stage clinical trial failed to prevent preterm births. The stock price plummeted $3.13 to close at $1.48.
posted by FC Market News at 10:20 AM
Monday, February 05, 2007
Previous Posts
- Triad To Go Private
- FTC Sets Royalties Cap For Rambus
- Millipore's Earnings Surge
- Medicare Proposes Expanding Stent Coverage
- Expenses To Rise For Illumina
- Intuitive Surgical's Forecast Impresses
- Earnings Plunge For Rackable Systems
- Secure Computing Beats Expectations
- W. P. Stewart CEO Retires
- Earnings Rise For Carbo Ceramics
0 Comments:
Post a Comment
<< Home